• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    $FER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALNY alert in real time by email

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.

    The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC).

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    As of December 2025, the Nasdaq-100 Index underpins more than 200 tracking products with over $600 billion in assets under management globally, including the Invesco QQQ Trust (QQQ®), which seeks to deliver investment results that, before expenses, correspond to the performance of the Nasdaq-100 Index. In addition to QQQ, a range of derivatives and structured instruments, such as futures, options, and other products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc. (NASDAQ:LULU), ON Semiconductor Corporation (NASDAQ:ON), The Trade Desk, Inc. (NASDAQ:TTD).

    Information

    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    • Alnylam Pharmaceuticals, Inc. – https://www.alnylam.com/
    • Ferrovial SE – https://www.ferrovial.com/
    • Insmed Incorporated – https://insmed.com/
    • Monolithic Power Systems, Inc. – https://www.monolithicpower.com/
    • Seagate Technology Holdings plc – https://www.seagate.com/
    • Western Digital Corp. – https://www.westerndigital.com/



    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, QQQ®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger

    Email: Maximilian.leitenberger@nasdaq.com



     Name: Index Client Services

    Email: indexservices@nasdaq.com

       

    NDAQF



    Primary Logo

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BIIB
    $CDW
    $FER

    CompanyDatePrice TargetRatingAnalyst
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    Insmed Incorporated
    $INSM
    1/28/2026$231.00Overweight
    Barclays
    Alnylam Pharmaceuticals Inc.
    $ALNY
    1/28/2026$527.00Overweight
    Barclays
    Seagate Technology Holdings PLC
    $STX
    1/28/2026$340.00 → $500.00Buy
    TD Cowen
    Insmed Incorporated
    $INSM
    1/23/2026$212.00Buy
    Roth Capital
    The Trade Desk Inc.
    $TTD
    1/23/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    ON Semiconductor Corporation
    $ON
    1/22/2026$62.00Underperform → Neutral
    BNP Paribas Exane
    Seagate Technology Holdings PLC
    $STX
    1/21/2026$380.00Neutral → Outperform
    BNP Paribas Exane
    More analyst ratings

    $ALNY
    $BIIB
    $CDW
    $FER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RF-Based VRU Safety Platforms Positioned for Institutional-Scale Growth

    Next-Generation RF Sensors Power the Future of Vulnerable Road User Protection NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Market News Updates News Commentary - The Vulnerable Road User (VRU) RF sensing platform market focuses on technology that helps vehicles and smart roads detect pedestrians, cyclists, and other people most at risk in traffic. These platforms use radio-frequency (RF) sensing, such as radar and mmWave, to "see" movement around vehicles in real time. Unlike cameras alone, RF sensing works well at night, in bad weather, and in crowded urban areas, making it a reliable safety solution as cities and vehicles become more automated.  Active Companies to keep a close eye on include: 

    2/6/26 9:15:00 AM ET
    $APTV
    $MGA
    $ON
    Auto Parts:O.E.M.
    Consumer Discretionary
    Semiconductors
    Technology

    Nasdaq 2026 Investor Day

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq will hold its 2026 Investor Day at the company's Global Headquarters in Times Square, New York. Due to limited capacity, in-person attendance is by invitation only. When: Wednesday, February 25, 2026  8:00 AM – 12:30 PM ETWhere:Webcast registration link: https://edge.media-server.com/mmc/p/u69c26de   The agenda, slide presentation and a live webcast will be available on the day of the event on Nasdaq's IR website: http://ir.nasdaq.com. A replay will be available after the conclusion of the event. About NasdaqNasdaq (NASDAQ:NDAQ) is a leading technology platform that powers the world's economies. We architect the world's most modern market

    2/5/26 4:05:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Monolithic Power Systems Announces CFO Transition

    SCHAFFHAUSEN, Switzerland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. ("MPS") (NASDAQ:MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced that Bernie Blegen will retire from his position as Executive Vice President and CFO effective following the issuance of MPS's 2025 annual report on Form 10-K. Mr. Blegen will remain with MPS after his retirement to ensure a smooth transition with his eventual successor. "Bernie started with MPS in 2011 as Corporate Controller when MPS was relatively small and only beginning to strategically diversify. In his ten years as CFO, MPS has grown consistently at

    2/5/26 4:02:00 PM ET
    $MPWR
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Desjardins Clarissa bought $201,694 worth of shares (3,025 units at $66.68) (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    5/22/25 5:20:35 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Reitan Colleen F bought $10,363 worth of shares (36 units at $287.85), sold $8,383 worth of shares (36 units at $232.86) and was granted 775 shares (SEC Form 4)

    4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Issuer)

    5/12/25 4:05:00 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Dorsa Caroline bought $151,559 worth of shares (1,235 units at $122.72), increasing direct ownership by 5% to 27,842 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    5/5/25 4:17:10 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Western Digital with a new price target

    TD Cowen reiterated coverage of Western Digital with a rating of Buy and set a new price target of $325.00 from $200.00 previously

    1/30/26 6:45:51 AM ET
    $WDC
    Electronic Components
    Technology

    Barclays initiated coverage on Insmed with a new price target

    Barclays initiated coverage of Insmed with a rating of Overweight and set a new price target of $231.00

    1/28/26 7:17:09 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays resumed coverage on Alnylam Pharma with a new price target

    Barclays resumed coverage of Alnylam Pharma with a rating of Overweight and set a new price target of $527.00

    1/28/26 7:15:18 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Massengill Matthew E sold $9,616,466 worth of shares (36,926 units at $260.43) (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:23 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Legal Officer & Corp Sec Tregillis Cynthia L sold $1,833,922 worth of shares (6,780 units at $270.49), decreasing direct ownership by 5% to 136,538 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/6/26 6:09:36 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Medical Officer Flammer Martina M.D. sold $132,470 worth of shares (869 units at $152.44), decreasing direct ownership by 1% to 83,243 units (SEC Form 4)

    4 - INSMED Inc (0001104506) (Issuer)

    2/6/26 4:18:50 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    SEC Filings

    View All

    SEC Form 144 filed by Monolithic Power Systems Inc.

    144 - MONOLITHIC POWER SYSTEMS INC (0001280452) (Subject)

    2/6/26 9:00:55 PM ET
    $MPWR
    Semiconductors
    Technology

    SEC Form 144 filed by Western Digital Corporation

    144 - WESTERN DIGITAL CORP (0000106040) (Subject)

    2/6/26 4:02:44 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 10-K filed by Biogen Inc.

    10-K - BIOGEN INC. (0000875045) (Filer)

    2/6/26 7:36:07 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Leadership Updates

    Live Leadership Updates

    View All

    GlobalFoundries Appoints Ganesh Moorthy to Board of Directors

    MALTA, N.Y., Jan. 15, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced the appointment of Ganesh Moorthy to its board of directors. Mr. Moorthy, former president and CEO of Microchip Technology Inc., joins GF's Board, effective immediately. Mr. Moorthy brings more than four decades of experience in the semiconductor industry, including transformative leadership at Microchip Technology, where he served as CEO, president and board member until his retirement in November 2024. He was appointed CEO and president in March 2021 and joined Microchip's Board of Directors in January 2021. Prior to that, he held senior leadership roles at Microchip including COO and execut

    1/15/26 8:30:00 AM ET
    $GFS
    Semiconductors
    Technology

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Maintains Over a Decade of Listings Leadership in 2025

    Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In addition, 22 companies transferred their corporate listings to Nasdaq in 2025 including Walmart, the largest exchange transfer in history. Since 2005, companies transferring their listing to Nasdaq have represented more than $4 trillion in total market value. "2025 marked a meaningful resurgence for the public markets. Companies at every stage continue to choose

    12/18/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Western Digital Corporation

    SC 13G/A - WESTERN DIGITAL CORP (0000106040) (Subject)

    11/14/24 1:22:34 PM ET
    $WDC
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Financials

    Live finance-specific insights

    View All

    RF-Based VRU Safety Platforms Positioned for Institutional-Scale Growth

    Next-Generation RF Sensors Power the Future of Vulnerable Road User Protection NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Market News Updates News Commentary - The Vulnerable Road User (VRU) RF sensing platform market focuses on technology that helps vehicles and smart roads detect pedestrians, cyclists, and other people most at risk in traffic. These platforms use radio-frequency (RF) sensing, such as radar and mmWave, to "see" movement around vehicles in real time. Unlike cameras alone, RF sensing works well at night, in bad weather, and in crowded urban areas, making it a reliable safety solution as cities and vehicles become more automated.  Active Companies to keep a close eye on include: 

    2/6/26 9:15:00 AM ET
    $APTV
    $MGA
    $ON
    Auto Parts:O.E.M.
    Consumer Discretionary
    Semiconductors
    Technology

    Monolithic Power Systems Provides Earnings Commentary for the Quarter and Year Ended December 31, 2025

    SCHAFFHAUSEN, Switzerland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- MPS reported its results after market close on February 5, 2026 and will host a question-and-answer webinar at 2:00 p.m. PT / 5:00 p.m. ET. The webinar can be accessed at https://mpsic.zoom.us/j/99373894222. 2025 Financial Summary (Unaudited) GAAP  20252024 YoY ChangeYoY Change (%)Revenue ($k)$ 2,790,459$ 2,207,100 $ 583,35926.4%Gross Margin55.2%55.3% (0.1) pts(0.2)%Opex ($k)$ 811,105$ 681,512 $ 129,59319.0%Operating Margin26.1%24.4% 1.7 pts7.0%Net income ($k)$ 615,927$ 1,786,700 $ (1,170,773)(65.5)%Diluted EPS$ 12.75$ 36.59 $ (23.84)(65.2)% Non-GAAP  20252024 YoY ChangeYoY Change (%)Revenue ($k)$ 2,790,459$ 2,207,100 $ 583,3

    2/5/26 4:01:00 PM ET
    $MPWR
    Semiconductors
    Technology

    Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026

    BRIDGEWATER, N.J., Feb. 5, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its fourth-quarter and full-year 2025 financial results on Thursday, February 19, 2026. Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, February 19, 2026, to discuss financial results and provide a business update. Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) an

    2/5/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care